Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-
alcoholic fatty liver disease) is a leading cause of chronic liver disease worldwide. MASLD …

Immunotherapy has made great strides in the treatment of lung cancer, but a significant
proportion of patients still do not respond to treatment. Therefore, the identification of novel …

Introduction With the advancements in early diagnosis, more and more patients with multiple
primary lung cancer (MPLC) have been identified. However, the progression of MPLC …

Background The cellular dynamics in the tumour microenvironment (TME) along with non‐
small cell lung cancer (NSCLC) progression remain unclear. Methods Multiplex …

Abstract Background Anti-PD-(L) 1 immunotherapy has been recommended for non-small
cell lung cancer (NSCLC) patients with lymph node metastases (LNM). However, the exact …

The impact of host condition on prognosis of non‐small cell lung cancer (NSCLC) and the
interaction between host and NSCLC remain unclear. This study investigated the …

The tumor microenvironment (TME) constitutes a complex microenvironment comprising a
diverse array of immune cells and stromal components. Within this intricate context, tumor …

Our current understanding of whether B cell involvement in the tumor microenvironment
benefits the patient or the tumor-in distinct cancers, subcohorts and individual patients-is …

The transcription factor forkhead box protein 3 (FOXP3) is considered to be a prominent
component of the immune system expressed in regulatory T cells (Tregs). Tregs are …

This study aimed to examine the spatial distribution of immune cells by application of Gcross
function in 170 patients with stage I to IIIA lung adenocarcinoma (LUAD) and explore its …